Mathew Blackman
Stock Analyst at Stifel
(3.69)
# 749
Out of 4,940 analysts
61
Total ratings
48.84%
Success rate
9.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $7.04 | -0.57% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $10.12 | +206.48% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $239.50 | +32.78% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $10.60 | +135.85% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $14.30 | +74.89% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $304.84 | -3.88% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $59.43 | +58.17% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $12.94 | +85.47% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.25 | +140.96% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $77.85 | +28.45% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $15.32 | +4.44% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.35 | +17.71% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $7.04
Upside: -0.57%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $10.12
Upside: +206.48%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $239.50
Upside: +32.78%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $10.60
Upside: +135.85%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $14.30
Upside: +74.89%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $304.84
Upside: -3.88%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $59.43
Upside: +58.17%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $12.94
Upside: +85.47%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.25
Upside: +140.96%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $77.85
Upside: +28.45%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $15.32
Upside: +4.44%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.35
Upside: +17.71%